These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 33572018)

  • 1. Development and dissemination of the national strategic action plan for reducing inappropriate polypharmacy in older Australians.
    Kouladjian O'Donnell L; Reeve E; Cumming A; Scott IA; Hilmer SN
    Intern Med J; 2021 Jan; 51(1):111-115. PubMed ID: 33572018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inappropriate polypharmacy management versus deprescribing: A review on their relationship.
    Zidan A; Awaisu A
    Basic Clin Pharmacol Toxicol; 2024 Jan; 134(1):6-14. PubMed ID: 37350370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polypharmacy, inappropriate prescribing, and deprescribing in older people: through a sex and gender lens.
    Rochon PA; Petrovic M; Cherubini A; Onder G; O'Mahony D; Sternberg SA; Stall NM; Gurwitz JH
    Lancet Healthy Longev; 2021 May; 2(5):e290-e300. PubMed ID: 36098136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of deprescribing in older adults with dementia: a narrative review.
    Sawan MJ; Moga DC; Ma MJ; Ng JC; Johnell K; Gnjidic D
    Expert Rev Clin Pharmacol; 2021 Nov; 14(11):1367-1382. PubMed ID: 34311630
    [No Abstract]   [Full Text] [Related]  

  • 5. Optimizing pharmacotherapy and deprescribing strategies in older adults living with multimorbidity and polypharmacy: EuGMS SIG on pharmacology position paper.
    van Poelgeest E; Seppala L; Bahat G; Ilhan B; Mair A; van Marum R; Onder G; Ryg J; Fernandes MA; Cherubini A; Denkinger M; Eidam A; Egberts A; Gudmundsson A; Koçak FÖK; Soulis G; Tournoy J; Masud T; Wehling M; van der Velde N;
    Eur Geriatr Med; 2023 Dec; 14(6):1195-1209. PubMed ID: 37812379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GP-Led Deprescribing in Community-Living Older Australians: An Exploratory Controlled Trial.
    Anderson K; Freeman C; Foster M; Scott I
    J Am Geriatr Soc; 2020 Feb; 68(2):403-410. PubMed ID: 31792947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thoughtful Prescribing and Deprescribing.
    Pravodelov V
    Med Clin North Am; 2020 Sep; 104(5):751-765. PubMed ID: 32773043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Deprescribing in Older Adults with Chronic Kidney Disease.
    Triantafylidis LK; Hawley CE; Perry LP; Paik JM
    Drugs Aging; 2018 Nov; 35(11):973-984. PubMed ID: 30284120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reducing potentially inappropriate polypharmacy at a national and international level: the impact of deprescribing networks.
    McDonald EG; Lundby C; Thompson W; Boyd C; Farrell B; Gagnon C; Herbin J; Khuong N; Moriarty F; Pierson T; Scott S; Scott IA; Silvius J; Spinewine A; Steinman MA; Tannenbaum C; Trimble J; Turner JP; Reeve E
    Expert Rev Clin Pharmacol; 2024; 17(5-6):433-440. PubMed ID: 38739460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combating Polypharmacy Through Deprescribing Potentially Inappropriate Medications.
    Chou J; Tong M; Brandt NJ
    J Gerontol Nurs; 2019 Jan; 45(1):9-15. PubMed ID: 30653232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Less Really Is More in Inappropriate Medication Use in Older Adults: How Can We Improve Prescribing and Deprescribing in Older Adults?
    Fick DM
    J Am Geriatr Soc; 2020 Jun; 68(6):1175-1176. PubMed ID: 32364621
    [No Abstract]   [Full Text] [Related]  

  • 12. Physicians need to take the lead in deprescribing.
    Scott IA; Le Couteur DG
    Intern Med J; 2015 Mar; 45(3):352-6. PubMed ID: 25735580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deprescribing in primary care in Portugal (DePil17-20): a three-phase observational and experimental study protocol.
    Simões PA; Santiago LM; Simões JA
    BMJ Open; 2018 Jul; 8(7):e019542. PubMed ID: 30018092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Patient Preferences in Deprescribing.
    Holmes HM; Todd A
    Clin Geriatr Med; 2017 May; 33(2):165-175. PubMed ID: 28364989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polypharmacy and deprescribing: just ask the patient.
    Cave JA
    Drug Ther Bull; 2020 Jan; 58(1):2. PubMed ID: 31727779
    [No Abstract]   [Full Text] [Related]  

  • 16. Polypharmacy, the Elderly, and Deprescribing.
    Jetha S
    Consult Pharm; 2015 Sep; 30(9):527-32. PubMed ID: 26350893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deprescribing: a new goal focused on the patient.
    Machado-Alba JE; Gaviria-Mendoza A; Machado-Duque ME; Chica L
    Expert Opin Drug Saf; 2017 Feb; 16(2):111-112. PubMed ID: 27984921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Considering Value in Prescribing and Deprescribing for Older Adults.
    Levinson W
    JAMA Netw Open; 2022 Feb; 5(2):e2148606. PubMed ID: 35166789
    [No Abstract]   [Full Text] [Related]  

  • 19. New horizons in deprescribing for older people.
    Woodford HJ; Fisher J
    Age Ageing; 2019 Nov; 48(6):768-775. PubMed ID: 31595290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of elderly patients with polypharmacy who refuse to participate in an in-hospital deprescribing intervention: a retrospective cross-sectional study.
    Komagamine J; Sugawara K; Hagane K
    BMC Geriatr; 2018 Apr; 18(1):96. PubMed ID: 29665778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.